SLA and infection: Following the infection with genotype II ASFV CN/GS/2018, the splenic MHC-II gene expression (SLA-DQA1, SLA-DQB1, SLA-DRA, SLA-DRB1, SLA-DMA, SLA-DMB, and SLA-DOA) decrease in T/B cells, DCs, NK cells, monocytes, macrophages, and neutrophils at 5–7 days post-infection.